论文部分内容阅读
目的:观察不同温的氨溴索雾化液对慢性阻塞性肺疾病急性发作患者患者适应性及临床效果。方法:选取95例慢性阻塞性肺疾病急性发患者随机分为对照组、观察I组和观察II组,3组均给予盐酸氨溴索雾化吸入治疗,对照组雾化液常温配置,观察I组和观察II组分别进行不同加温雾化吸入,7天为一个疗程,观察依从性及临床效果。结果:雾化吸入前后观察I组和观察II组与对照组比较舒适度差异有统计学意义(与对照组比较,P<0.05),观察I组和观察II组排痰、止喘效果好于对照组(P<0.05)。结论:加温的盐酸氨溴索雾化液对慢性阻塞性肺疾病急性发作患者有更好的舒适度和临床效果。
OBJECTIVE: To observe the adaptability and clinical effect of different temperature ambroxol spray in patients with acute exacerbation of chronic obstructive pulmonary disease. Methods: A total of 95 patients with acute obstructive pulmonary disease were randomly divided into control group, observation group I and observation group II, three groups were given ambroxol hydrochloride inhalation treatment, Group and observation group II were heated at different temperatures inhalation, 7 days for a course of treatment to observe the compliance and clinical effects. Results: Before and after nebulization, there was significant difference in comfort between group I and group II and control group (P <0.05 compared with control group), and group I and group II had better expectoration effect than group C Control group (P <0.05). Conclusions: Warmed ambroxol hydrochloride nebulizer has better comfort and clinical effect in patients with acute exacerbation of chronic obstructive pulmonary disease.